| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 28 | 2025 | 651 | 5.650 |
Why?
|
| Heart | 11 | 2024 | 736 | 3.010 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 12 | 2021 | 16 | 2.370 |
Why?
|
| Cardiotoxicity | 3 | 2020 | 35 | 2.040 |
Why?
|
| Myocardium | 10 | 2025 | 1029 | 1.550 |
Why?
|
| Tissue Culture Techniques | 2 | 2024 | 67 | 1.540 |
Why?
|
| Myocardial Infarction | 7 | 2025 | 1054 | 1.440 |
Why?
|
| Biomimetics | 2 | 2022 | 18 | 1.430 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2022 | 199 | 1.340 |
Why?
|
| Heart Failure | 8 | 2025 | 2309 | 1.230 |
Why?
|
| Enzyme Inhibitors | 2 | 2023 | 592 | 1.010 |
Why?
|
| Fibroblasts | 7 | 2025 | 888 | 0.900 |
Why?
|
| Cardiomegaly | 5 | 2022 | 135 | 0.870 |
Why?
|
| Calcium-Transporting ATPases | 4 | 2021 | 56 | 0.860 |
Why?
|
| Rats | 14 | 2025 | 3763 | 0.830 |
Why?
|
| Organ Culture Techniques | 2 | 2020 | 154 | 0.800 |
Why?
|
| Animals | 37 | 2025 | 34533 | 0.790 |
Why?
|
| Signal Transduction | 18 | 2024 | 4638 | 0.780 |
Why?
|
| Myocardial Ischemia | 2 | 2024 | 349 | 0.770 |
Why?
|
| Cell Cycle | 6 | 2024 | 612 | 0.760 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2011 | 31 | 0.750 |
Why?
|
| Cellular Reprogramming | 5 | 2024 | 115 | 0.730 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2023 | 167 | 0.710 |
Why?
|
| Swine | 5 | 2024 | 1183 | 0.710 |
Why?
|
| Cardiotoxins | 1 | 2020 | 6 | 0.700 |
Why?
|
| Heart Ventricles | 3 | 2020 | 784 | 0.690 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 88 | 0.670 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 71 | 0.660 |
Why?
|
| GATA4 Transcription Factor | 4 | 2024 | 41 | 0.650 |
Why?
|
| Ventricular Function | 1 | 2019 | 91 | 0.610 |
Why?
|
| Models, Biological | 4 | 2020 | 1469 | 0.590 |
Why?
|
| Cell Membrane | 3 | 2016 | 467 | 0.590 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 250 | 0.580 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 265 | 0.550 |
Why?
|
| Dioxoles | 1 | 2016 | 11 | 0.540 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2016 | 39 | 0.530 |
Why?
|
| Benzamides | 1 | 2016 | 114 | 0.510 |
Why?
|
| Transcription Factors | 4 | 2024 | 2618 | 0.490 |
Why?
|
| Cyclic GMP | 3 | 2011 | 95 | 0.460 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1725 | 0.450 |
Why?
|
| Green Fluorescent Proteins | 2 | 2023 | 389 | 0.430 |
Why?
|
| Cyclic AMP | 2 | 2011 | 247 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 475 | 0.430 |
Why?
|
| Mice | 21 | 2025 | 17881 | 0.420 |
Why?
|
| Cell Proliferation | 7 | 2022 | 2394 | 0.420 |
Why?
|
| Calmodulin | 2 | 2013 | 224 | 0.410 |
Why?
|
| Stroke Volume | 3 | 2025 | 501 | 0.400 |
Why?
|
| p21-Activated Kinases | 3 | 2024 | 58 | 0.390 |
Why?
|
| Genes, Reporter | 1 | 2013 | 382 | 0.390 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 100 | 0.390 |
Why?
|
| Muscle Proteins | 3 | 2014 | 416 | 0.370 |
Why?
|
| Mammals | 2 | 2023 | 257 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 683 | 0.360 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 62 | 0.360 |
Why?
|
| Cells, Cultured | 8 | 2020 | 3040 | 0.340 |
Why?
|
| Humans | 37 | 2025 | 126330 | 0.340 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 771 | 0.340 |
Why?
|
| Enzyme Assays | 1 | 2010 | 11 | 0.330 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2020 | 160 | 0.310 |
Why?
|
| Cell Differentiation | 4 | 2024 | 1931 | 0.300 |
Why?
|
| T-Box Domain Proteins | 3 | 2019 | 116 | 0.300 |
Why?
|
| Calcium Signaling | 4 | 2015 | 246 | 0.300 |
Why?
|
| Calcineurin | 4 | 2014 | 100 | 0.290 |
Why?
|
| MEF2 Transcription Factors | 2 | 2019 | 41 | 0.290 |
Why?
|
| Mice, Knockout | 8 | 2021 | 3777 | 0.270 |
Why?
|
| Ventricular Remodeling | 2 | 2025 | 185 | 0.270 |
Why?
|
| Membrane Proteins | 3 | 2025 | 1551 | 0.250 |
Why?
|
| Pyruvate Kinase | 1 | 2025 | 11 | 0.240 |
Why?
|
| Lipid Metabolism | 2 | 2025 | 356 | 0.240 |
Why?
|
| Aurintricarboxylic Acid | 2 | 2016 | 2 | 0.240 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2025 | 30 | 0.240 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2024 | 27 | 0.230 |
Why?
|
| Glycolysis | 2 | 2022 | 154 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 467 | 0.230 |
Why?
|
| Dermoscopy | 1 | 2023 | 2 | 0.220 |
Why?
|
| Hair | 1 | 2023 | 24 | 0.210 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2021 | 463 | 0.210 |
Why?
|
| Hair Follicle | 1 | 2023 | 34 | 0.210 |
Why?
|
| Alopecia | 1 | 2023 | 39 | 0.210 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 170 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2023 | 126 | 0.210 |
Why?
|
| Electric Stimulation | 1 | 2024 | 328 | 0.200 |
Why?
|
| Calcium | 3 | 2013 | 1111 | 0.200 |
Why?
|
| Aldosterone | 1 | 2022 | 56 | 0.200 |
Why?
|
| Renin | 1 | 2022 | 84 | 0.200 |
Why?
|
| Genetic Therapy | 2 | 2024 | 691 | 0.200 |
Why?
|
| Apoptosis | 4 | 2020 | 1839 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 210 | 0.200 |
Why?
|
| Animals, Newborn | 3 | 2016 | 1024 | 0.190 |
Why?
|
| Endothelial Cells | 3 | 2023 | 508 | 0.190 |
Why?
|
| Systole | 1 | 2022 | 201 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 105 | 0.190 |
Why?
|
| Culture Media | 1 | 2022 | 181 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2022 | 101 | 0.190 |
Why?
|
| Cell Division | 1 | 2023 | 762 | 0.190 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 225 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 589 | 0.190 |
Why?
|
| Heart Diseases | 2 | 2020 | 503 | 0.180 |
Why?
|
| Microsomes | 2 | 2013 | 55 | 0.180 |
Why?
|
| Sphingosine | 2 | 2011 | 12 | 0.180 |
Why?
|
| Toxicity Tests | 1 | 2020 | 35 | 0.170 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 4467 | 0.170 |
Why?
|
| Technology | 1 | 2020 | 67 | 0.170 |
Why?
|
| Trastuzumab | 1 | 2020 | 136 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 1261 | 0.170 |
Why?
|
| Male | 13 | 2025 | 62031 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 375 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 194 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 506 | 0.160 |
Why?
|
| Sheep | 1 | 2020 | 220 | 0.160 |
Why?
|
| Regeneration | 2 | 2021 | 213 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2024 | 1204 | 0.160 |
Why?
|
| Doxorubicin | 1 | 2020 | 290 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 3 | 2014 | 326 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2428 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 520 | 0.150 |
Why?
|
| Cyclin B1 | 1 | 2018 | 8 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4466 | 0.150 |
Why?
|
| CDC2 Protein Kinase | 1 | 2018 | 34 | 0.140 |
Why?
|
| Malvaceae | 1 | 2017 | 1 | 0.140 |
Why?
|
| Models, Animal | 1 | 2020 | 459 | 0.140 |
Why?
|
| Antimutagenic Agents | 1 | 2017 | 2 | 0.140 |
Why?
|
| Cytokinesis | 1 | 2018 | 26 | 0.140 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 76 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 59 | 0.140 |
Why?
|
| Cyclin D1 | 1 | 2018 | 115 | 0.140 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2017 | 31 | 0.140 |
Why?
|
| Adult | 4 | 2023 | 29802 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 215 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 868 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2017 | 126 | 0.130 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 85 | 0.130 |
Why?
|
| Pressure | 1 | 2016 | 132 | 0.120 |
Why?
|
| Metabolomics | 1 | 2019 | 427 | 0.120 |
Why?
|
| Kidney | 1 | 2022 | 1361 | 0.120 |
Why?
|
| Cell Shape | 1 | 2015 | 63 | 0.120 |
Why?
|
| Wnt Proteins | 1 | 2016 | 217 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 237 | 0.120 |
Why?
|
| Antioxidants | 1 | 2017 | 356 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 72 | 0.120 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2014 | 21 | 0.110 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2014 | 3 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 980 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 741 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2014 | 70 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2014 | 746 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 654 | 0.110 |
Why?
|
| Caveolae | 1 | 2013 | 7 | 0.110 |
Why?
|
| Cell Line | 4 | 2017 | 2734 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 566 | 0.110 |
Why?
|
| Propylene Glycols | 2 | 2011 | 19 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 219 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2276 | 0.100 |
Why?
|
| Adenoviridae | 2 | 2013 | 602 | 0.100 |
Why?
|
| Female | 6 | 2023 | 67333 | 0.100 |
Why?
|
| Adenosine Diphosphate | 1 | 2013 | 54 | 0.100 |
Why?
|
| Transcriptome | 1 | 2019 | 1013 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2016 | 797 | 0.100 |
Why?
|
| Contraception | 1 | 2013 | 58 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2014 | 262 | 0.100 |
Why?
|
| Aorta | 1 | 2016 | 548 | 0.100 |
Why?
|
| Malaria | 1 | 2013 | 88 | 0.100 |
Why?
|
| Nitric Oxide | 3 | 2011 | 485 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 371 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 413 | 0.100 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2014 | 530 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 280 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2012 | 128 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 102 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 469 | 0.090 |
Why?
|
| Ion Transport | 1 | 2011 | 53 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1280 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 31 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2011 | 28 | 0.090 |
Why?
|
| Middle Aged | 3 | 2020 | 27031 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2014 | 783 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2011 | 140 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2013 | 942 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2009 | 66 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 114 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 1560 | 0.080 |
Why?
|
| Protein Binding | 4 | 2019 | 1749 | 0.070 |
Why?
|
| Troponin I | 1 | 2009 | 109 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 2542 | 0.070 |
Why?
|
| NFATC Transcription Factors | 3 | 2014 | 44 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 495 | 0.070 |
Why?
|
| Sarcolemma | 1 | 2006 | 23 | 0.070 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 94 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3622 | 0.060 |
Why?
|
| Myofibroblasts | 1 | 2025 | 78 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2024 | 16 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 1838 | 0.060 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 28 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2024 | 38 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 19962 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 685 | 0.050 |
Why?
|
| Diastole | 1 | 2023 | 178 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2014 | 19 | 0.050 |
Why?
|
| Dependovirus | 1 | 2023 | 129 | 0.050 |
Why?
|
| Phenylephrine | 2 | 2014 | 38 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 765 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 295 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 438 | 0.050 |
Why?
|
| Cell Survival | 2 | 2017 | 835 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2022 | 75 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 2071 | 0.050 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 24 | 0.050 |
Why?
|
| Heart Injuries | 1 | 2021 | 46 | 0.050 |
Why?
|
| Cell Plasticity | 1 | 2021 | 33 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2021 | 42 | 0.040 |
Why?
|
| Pertussis Toxin | 2 | 2011 | 28 | 0.040 |
Why?
|
| Fingolimod Hydrochloride | 2 | 2011 | 34 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 677 | 0.040 |
Why?
|
| Transfection | 2 | 2014 | 1073 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2024 | 828 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2011 | 973 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 122 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2010 | 631 | 0.040 |
Why?
|
| Comet Assay | 1 | 2017 | 12 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 80 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 89 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 51 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2019 | 353 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 483 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2010 | 689 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 117 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 343 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1306 | 0.030 |
Why?
|
| Machine Learning | 1 | 2019 | 257 | 0.030 |
Why?
|
| Sarcomeres | 1 | 2016 | 32 | 0.030 |
Why?
|
| Fruit | 1 | 2017 | 222 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1640 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 248 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 423 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2015 | 61 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 298 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 342 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 305 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 82 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 127 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 718 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 97 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 146 | 0.030 |
Why?
|
| Chromatin | 1 | 2016 | 578 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1647 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3449 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 32 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 315 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 512 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 881 | 0.020 |
Why?
|
| Time Factors | 2 | 2014 | 6334 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2012 | 217 | 0.020 |
Why?
|
| Biotransformation | 1 | 2011 | 49 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 564 | 0.020 |
Why?
|
| Sphingolipids | 1 | 2011 | 28 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 102 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 64 | 0.020 |
Why?
|
| Ischemia | 1 | 2014 | 362 | 0.020 |
Why?
|
| Coronary Occlusion | 1 | 2011 | 29 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 856 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 180 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2009 | 5 | 0.020 |
Why?
|
| Sinoatrial Node | 1 | 2009 | 22 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 89 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 49 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 141 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 93 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1110 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 382 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2009 | 136 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 228 | 0.020 |
Why?
|
| Dystrophin | 1 | 2006 | 42 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 943 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2818 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 2549 | 0.010 |
Why?
|